Treatment for liver cancer: From sorafenib to natural products-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment for liver cancer: From sorafenib to natural products

Published:2021-11 Issue: Volume:224 Page:113690
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Man Shuli,Luo Chen,Yan Mengyao,Zhao Ganggang,Ma Long,Gao Wenyuan

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference117 articles.

1. Cancer statistics;Siegel;CA A Cancer J. Clin.,2019

2. Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights;Xie;Hepatobiliary Surg. Nutr.,2019

3. Emerging agents and regimens for hepatocellular carcinoma;Zhu;J. Hematol. Oncol.,2019

4. Natural products as sources of new drugs from 1981 to 2014;Newman;J. Nat. Prod.,2016

5. Anticancer drugs from traditional toxic Chinese medicines;Man;Phytother Res. : PTR,2012

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disulfidptosis-related gene expression reflects the prognosis of drug-resistant cancer patients and inhibition of MYH9 reverses sorafenib resistance;Translational Oncology;2024-11

2. Anti-liver cancer effects and mechanisms and its application in nano DDS of polysaccharides: A review;International Journal of Biological Macromolecules;2024-11

3. Exploring the antimicrobial activity of rare ginsenosides and the progress of their related pharmacological effects;Phytomedicine;2024-10

4. Poly(lactic acid hydroxyacetic acid)-poly(ethylene glycol)-modified ginsenoside Rg3 nanomedicine enhances anti-tumor effect in hepatocellular carcinoma;Drug Development and Industrial Pharmacy;2024-09-11

5. Exploring the mechanism of genistein in treating hepatocellular carcinoma through network pharmacology and molecular docking;Oncologie;2024-09-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3